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Original Article
Myasthenia Gravis – Phenotypic Characters and Course in a
South Indian Population
Dr. S.R.Chandra*, Dr. Sinchu Mangett**
ABSTRACT
This study reports the three years
experience of Government Medical College,
Trivandrum in patients with Myasthenia Gravis.
Analysis of phenotypic characters, correlation
with age, sex, antibody response, thymic
tumours, morbidity, mortality and course are
analyzed. The study reveals males were affected
than females. Ocular onset is commonest but
more than fifty percent turned generalized. Crisis
occurred in 22%, which was heralded by drug
default or infection in majority of cases.
Generalized myasthenia and thymoma-associated
patients carry higher risk of crisis. More than
one hospital admission was needed in 28% only.
No definite correlation between clinical course
and antibody status was observed in contrast to
the study reported from Karnataka. Good quality
of life is achieved in majority of patients though
full immunological, electrophysiological remission
is not always reached.
Key Words
Myasthenia gravis, AChRAb, Quality of
life.
INTRODUCTION
Myasthenia gravis is a well known disease
of neuromuscular junction transmission. It was
first described by Thomas Willis – 17th century
physician in 1672 1. Friedrich Jolly called it as
pseudoparalysis. Lindsay in 1899 introduced the
term Myasthenia gravis. In 1934, Mary Walker
of St. Alfege’s hospital described the use of
anticholinesterase. The autoimmune nature was
established in 19732. However, the factors that
initiate, sustain or produce remissions is not very
clear. In 1984, Gourie devi et al reported a
prevalence of 2/100,000 population3, female to
male ratio is 57:43, average age of onset is 28
for females and 42 for males but after 50 years
males are more affected4. Thymus,
anti-acetylcholine receptor antibody
(anti-AChRAb) and anti-muscle specific kinase
(anti-MUSK) antibody are etiologically
implicated5. Here we analyze the role of
phenotypic characters like generalized, ocular,
bulbar, limb onset and the presence of
anti-AChRAb, thymoma and other comorbidities
in predicting the prognosis and outcome.
PATIENTS AND METHODS
We analyzed all the patients with
Myasthenia Gravis treated in the neuromedicine
department of Government Medical College,
Trivandrum from the year 2005 January to 2008
January. All patients had fatigable muscle
weakness involving ocular, bulbar, neck and or
all muscles. All patients were evaluated using
Myasthenia Gravis Foundation of America scale
(MGFA)6. Maximum scale reached by the patient
is crisis and intubation5. Post intervention scale
was used to measure outcome. Patients score in
the last outpatient follow-up was compared to the
maximum score reached by the patient. Poor
outcome was considered under the following
situation, death, MGFA scores unaltered or
worsening, need for pyridostigmine more than
120 mg per day or prednisolone dose required
more than 0.5 mg / kg for maintenance. All
patients had positive response to neostigmine and
had more than 10% decrement in repetitive nerve
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stimulation test conducted in the
electroneuromyography laboratory of the
government medical college hospital, Trivandrum,
Kerala state, South India. The CT mediastinum
was done in the radiology department of the
same institution. Thyroid profile and
anti-AChRAb were also done. Anti-MUSK Ab
were not done in any case. Anti-AChRAb was
reflected at the end of one year of treatment in
32 patients. 26 patients remained positive.
Repetitive nerve stimulation (RNS) was done on
three sites - nasalis, trapeziuus and abductor
digiti minimi on the right side. Nasalis: R1 was
kept at midpoint of nasalis and R2 above
eyebrow. Stimulation was given below and
anterior to tragus. Trapezius : R1 was kept
midway between acromion and C7 spine and R2
at glabellar point and stimulated behind
sternocleidomastoid midpoint between clavicle
and mastoid. Abductor digiti minimi : R1 kept
over middle of hypothenar muscles and R2 at
base of 5th digit and stimulated from wrist.
Supramaximal stimulation was used at the
stimulating site7. Slow RNS (3Hz) was performed
at rest, 30 seconds postexercise and repeated
every minute for 5 minutes. The amplitude of the
CMAP was measured from base to peak.
Decrement confined to nasalis was labeled ocular
and any of the other muscles if involved was
considered as generalized. Single fibre EMG was
not done in any case. At the end of one year
RNS was repeated in all patients. It was
performed after discontinuing pyridostigmine for
eight hours and 52% patients revealed
normalization in all the muscles tested.
DATA ANALYSIS AND STATISTICAL
METHODS
Total patients with myasthenia gravis
seen were seventy three. However investigations
were completed only in fifty cases. Among these
50 patients there were twenty three females and
twenty seven males. There age group varied from
eleven years to sixty-five years. Mean age was
39 years. In the age group between 11 years to
19 years there were 5 female patients. In the 20
to 29 years age group there were eight patients,
three males and five females. In the 30 to 39
years age group there were 10 patients , 6 males
and 4 females. In the 40 to 49 years age group
thirteen patients, eight males and five females.
In the 50 to 59 years age group seven patients,
6 males and one female. In the age group 60
and above, 7 patients 4 males and 3 females.
Females seen to dominate before 3rd decade and
males dominated after 4th decade. The duration
of disease varied from few months to eleven
years. Total hospital admission was only once in
36 patients, twice in 9 patients, thrice in three
patients, 4 times in one patient, 6 times in one
patient in the last 3 years. First presenting
symptom was ocular in 40 patients, bulbar in 2
patients and limb onset in 7 patients. However
after evaluation 35 patients were generalized of
which 5 were limb onset type, one neck flop
onset, 2 bulbar onset type and 22 were ocular
onset type. AChR Ab (direct ELISA method only)
was considered negative if titres were less than
25, positive if more than 40 and equivocal if
between 25 and 40. It was negative in nine all
of whom were ocular onset. Among the ocular
onset type AchRAb was negative in nine, and
positive in 31 out of which nine were ocular only
and 22 were ocular with generalized. Equivocal
in seven cases, none were ocular onset type.
Anti-MUSK Ab were not done in any case.
Thymic tumour was detected in 5 patients , there
were 3 females and 2 males. One female had
thymic lipoma and others had thymoma. Thyroid
profile done in 18 patients based on clinical
suspicion showed T3 of 415,552,536 in 3 cases,
One female and 2 males (normal range 70 to 204)
T4 levels were 14, 22, 28 ug, two male and one
female (normal range 5-12). TSH 0.005, 0.65,
0.014, 0.01 one female and three males (normal
range 0.3 to 5.5) suggests hyperthyroidism in 4
patients – 3 males and 1 female. Low T3 was
found in none. T4 was low in 2 cases, 2.9 and
4.1 (range 5 to 12) both were females.
Myasthenic crisis occurred in 11 patients
during the 3 year period. Three were females and
nine were males. Three of these patients had
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undergone thymectomy. Drug default was the
cause of crisis in four patients. Five patients had
pneumonia as a complicating problem. Two
patients succumbed and others survived. One
patient was on treatment for reactive depression
and commited suicide and died. The mean age
of the patients was 39.2 +/- 14.76 years. Males
mean age was 44.33 +/- 12.55. Mean age for
female is 33.17 +/- 15.12, p value 0.006. Male
patients are significantly older compared to
female patients. Evaluation of relationship
between gender and ocular versus non-ocular
presentation using chi square test showed no
significant association. Mortality is 6% of which
4% is myasthenic crisis related, 2% is due to
reactive depression. Myasthenic crisis was seen
in 22% of cases. Among those with crisis 45%
were due to pneumonia, 36% due to drug default
and 9% was unexplained cause. All the patients
who had myasthenia crisis belonged to
generalized myasthenia. 27% of patients who had
crisis were patients with thymoma in post
thymectomy phase.
DISCUSSION
This present study consists of fifty patients
with myasthenia gravis confirmed by clinical
examination, pyridostigmine test, RNS at rest
and post exercise and Anti-AChR antibodies
titres. The study period is three years. The mean
age of patients is 39 years. Male patients were
significantly older compared to females. However
no significant gender differences exist between
ocular versus non ocular group. Limb onset is
found in 10% of patients suggesting that careful
evaluation of patients presenting with limb girdle
syndrome is likely to be rewarding.
Thymoma is found in about 10% of
patients and except the one patient with thymic
lipoma, the thymoma group appears to be most
prone for crisis. Prognosis does not seem to be
altered by the seropositivity for AChRAb
positivity in contrast to short communication
reported from another study from South India 8.
Crisis is often precipitated by infection. Hence
protection from infection and once they occur
aggressive treatment of infection is very
important.
Nearly fifty percent of patients with ocular
onset turned generalized later. Quality of life can
be maintained by regular follow up, proper
adherence to the drug regimen and careful
monitoring of adverse effects and comorbidities
management. Patients also need counseling as
the treatment is prolonged. Even though
immunological and electrophysiological remission
is not easily attained effective control of the
clinical symptoms can be achieved.
Chart 1: General Details of all Patients
No. Name Age Sex Onset Initial
Sympto
m
Type MG
crisis
Steroids Thymom
a
Thymec
tomy
IVIG Adm AChRA
b
TFT Sur
1 G 60 M 58 P G N Y ** N N 1 − 
2 S 33 F 33 P O N N Y Y N 1 +
3 SD 57 M 57 L G Y Y N N N 3 −
4 P 25 F 15 P G Y Y NA NA N 1 +
5 F 43 F 39 P O N Y Y Y N 2 −
6 J 62 F 62 P G N Y N N N 2 −
7 RK 33 M 27 P O N Y N Y N 1 +
8 V 43 M 43 P G Y Y Y Y N 3 +
9 T 54 M 54 N G N Y NA NA N 1 −
10 S 35 F 34 B G Y Y Y Y Y 1 Equivocal
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No. Name Age Sex Onset Initial
Sympto
m
Type MG
crisis
Steroids Thymom
a
Thymec
tomy
IVIG Adm AChRA
b
TFT Sur
11 Y 51 M 48 P G Y Y Y Y Y 6 +
12 N 22 F 22 B G N N N N N 1 −
13 S 53 M 52 P G N Y N N N 1 −
14 S 51 F 50 D G N N NA NA N 1 −
15 S 13 F 13 P O N N NA NA N 1 +
16 N 31 M 30 P G Y Y N Y Y 1 +
17 V 38 M 38 D G Y Y NA NA Y 2 − I, 
18 S 21 M 20 P G Y Y N Y N 3 +
19 N 45 F 45 P G N N Y N N 2 +
20 S 40 F 36 P O N Y NA NA N 2 +
21 UM 65 M 65 P G N Y NA NA N 1 −
22 V 61 M 50 P O N N N N N 1 −
23 S 15 F 15 L G N N NA NA N 1 +
24 M 47 M 47 P O N N NA NA N 1 +
25 P 48 M 48 L G N Y Y Y N 4 +
26 K 35 F 35 P G N N N N N 2 +
27 R 12 F 12 P G N N NA NA N 1 +
28 S 35 M 34 P G N Y N N N 1 + I
29 SK 29 F 29 P O N N NA NA N 1 + I
30 S 16 F 16 P O N N NA NA N 1 +
31 R 25 F 25 P O N Y Y Y N 2 +
32 R 45 M 45 P O N N NA NA N 1 −
33 I 32 M 32 D G N Y NA NA N 2 +
34 VN 55 M 55 D O N Y N N N 1 −
35 A 11 F 11 P O N N N N N 1 +
36 KK 31 M 31 P G Y Y NA NA N 2 + I
37 SK 49 F 44 P G N Y NA NA N 1 + D
38 L 41 F 41 D O N N NA NA N 1 + D
39 FP 37 F 37 D G N N Y Y N 1 +
40 H 23 F 23 L G Y Y NA NA Y 1 +
41 N 40 M 38 P O N N NA NA N 1 −
42 J 63 F 60 P G N Y NA NA N 1 −
43 RK 58 M 43 L G Y Y Y Y Y 1 +
44 I 38 F 37 P G N N NA NA N 1 +
45 M 48 M 47 P O N N NA NA N 1 −
46 S 60 M 60 D G N N N N N 1 −
47 R 40 M 35 P O N Y N N N 1 +
48 O 21 M 21 D O N N NA NA N 1 +
49 S 43 M 43 P O N Y N N N 1 −
50 A 27 M 27 D O N Y N N N 1 +
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CHART 2 Patients with Myasthenic Crisis 11 Patients
Name Age Gender Duration Crisis factor AchRAb Thymect
omy
Steroids IVIG PLEX Survival
S 57 M 1 57 Default − − + − − +
P 25 F 10 25 Pneumo
nia
+ − + − − +
V 43 M 1 ? Default + + + + − +
S 34 F 1 35 Pneumo
nia
Borderlin
e
+ + + − +
Y 48 M 3 51 Pneumo
nia
+ + + + − Died
V 38 M 1 38 ?unexpla
ined
− Nil + + − +
S 21 M 1 21 Pneumo
nia
+ + + + + Died
N 30 M 1 31 Default + − + − + +
KK 31 M 1 31 Default + − + − + +
H 23 F 1 23 Pneumo
nia
+ − + + − +
RK 43 M 1 43 default + Y + − + +
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Review Article
Toxicology clinics-bench to bed side Antimuscarnic therapy in
organophosphate poisoning
Dr.S.Senthil Kumaran*, Dr.N.Balamurgan**, Dr.V.Karthikeyan***
Unintentional and intentional
organophosphate (OP) poisonings continue to be
a significant cause of morbidity and mortality in
our country. Basic pharmacology and animal
work suggests that early antagonism of pesticide
toxicity should be associated with better
outcomes. The principles of therapy in OPC
poisoning include resuscitation of patient (patent
airway, effective breathing and adequate
circulation), high flow oxygen, a muscarinic
antagonist and fluids. The role of oximes is
dubious. Therefore, atropine is the mainstay of
therapy. Atropine blocks muscarinic receptors
limiting neuro-effector transmission by excessive
acetylcholine. In this issue we have tried to
answer some important FAQs on antimuscarnic
therapy with available evidences.
Does the patient need atropine?
The important features of OPC poisoning
are miosis, bronchospasm /bronchorrhoea,
bradycardia, hypotension and excessive sweating.
The presence of these cholinergic signs suggests
that the patient has taken an OP compound and
requires atropine.
If none of the signs are present, patient
does not require atropine but careful observation
is required to look for the development of
cholinergic signs. This is because signs may be
delayed due to a pro-poison (thion) OP getting
converted to an active oxon form, and being
released into the blood later or if the patient has
presented soon after the ingestion.
Is there any contraindication for atropine?
No absolute contraindication for atropine
in OPC poisoning.
How much atropine he needs?
The aim of atropine therapy is to reverse
the cholinergic features and improve cardiac and
respiratory function as quickly as possible.
Severely poisoned patients may require hundreds
of milligrams of atropine.
How to give atropine?
An initial bolus of intravenous atropine,
1–2 mg (into a fast-flowing infusion) should be
given. Atropine takes only a few minutes to act
and blood levels peaks within three minutes after
an intravenous administration. Waiting just five
minutes for a response before deciding whether
to give another dose is probably sufficient.
Therefore, if a consistent improvement in
the cholinergic features does not occur within 3-5
minutes after the initial loading dose, the
recommendation is to double the dose, and
continue to double the dose until atropinisation
is achieved. Do not simply repeat the initial dose
of atropine.
This regimen requires no more than 20
minutes to administer 25 mg of atropine.
Can I give large initial bolus doses of
atropine of 50 mg or so?
No, this is dangerous and may result in
cardiac failure due to greatly increased
peripheral resistance, and tachycardia which
results in the diminished diastolic filling time.
Is he atropinised?
There should be a uniform improvement
in most of the cholinergic signs, not
improvements in just one. However, the most
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important parameters are air entry on chest
auscultation, heart rate, and blood pressure.
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There is no need to aim for a heart rate
of 120–140 beats/min. Such high heart rates will
cause particularly severe complications in older
patients with pre-existing cardiac disease –
myocardial infarctions may result.
   	 
Once atropinised (with clear lungs,
adequate heart rate [more than 80 beats/min]
and blood pressure [more than 80 mmHg systolic
with good urine output], dry skin, and pupils no
longer pinpoint) an infusion of atropine is started
to maintain blood atropine concentration in the
therapeutic range, reducing fluctuation compared
with repeated bolus doses.
    
In the infusion, try to give 10 – 15% of
the total amount of atropine required to load the
patient and it has to be given every hour as an
intravenous infusion. The maintenance dose
should be titrated against symptoms. The
infusion rate should be sufficient and there
should not be any signs of atropine toxicity.
     
The atropine infusion need to be continued
for 48hours and tapered over 3-4 day
      
Excess atropine causes agitation,
confusion, urinary retention, hyperthermia, bowel
ileus and tachycardia.
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Stop the atropine infusion. Check again
after 30 min to see whether the features of
toxicity have settled. If not, continue to review
every 30 min or so. When they settle, restart at
60–70% of the previous rate. The patient should
then be seen frequently to ensure that the new
infusion rate has reduced the signs of atropine
toxicity without permitting the reappearance of
cholinergic signs.
     
Yes, it’s Glycopyrrolate. 
This is a quarternary ammonium
antimuscarinic agent with peripheral effects
similar to those of atropine. It is a longer acting
drug which does not cross the blood–brain barrier
and therefore does not counteract the central
nervous system effects of the poison. However, it
is a more effective antisialagogue than atropine.
It is less likely to cause much tachycardia and
blocks bradyarrythmias effectively.
    
No, an animal study demonstrates early
death in OPC poisoning appears to be a centrally
mediated process. The peripherally acting
cholinergic agents like glycopyrrolate will not
prevent the early death. So initially start with
atropine and slowly change into glycopyrrolate.
This combination works better.

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Original Article
Chennai Slim and Fit Programme:
Awareness and perceptions related to obesity among urban
children and adolescents
Dr. Shabana Tharkar., Dr. Vijay Viswanathan
Abstract
Background & Objectives The aim of the
study was to assess the knowledge levels of
children and adolescents on obesity and their
lifestyle practices related to diet and physical
activity.
Methods: About 1266 school children aged 8- 16
years were surveyed by an interviewer
administered questionnaire. Scores were allotted
for the knowledge questions and maximum
attainable score was 8. Chi square or z test was
done as appropriate to determine the significance
testing between groups.
Results: The children generally had poor
knowledge on obesity and its related factors.
Eventhough most of them had heard of diabetes,
knowledge on prevention was very scarce. The
mean knowledge score of children from high
socioeconomic status was 4.6 and those from low
socioeconomic status were 3.1. Higher knowledge
levels were seen among females and children
from high socioeconomic status (p<0.0001). The
practices of children were unhealthy and
sedentary, only 35 % of the children had daily
one hour physical activity.
Conclusion: The knowledge of the children on
obesity and diabetes is grossly inadequate and
awareness programmes are needed to improve
their knowledge levels. They must be motivated
to practice healthy lifestyle.
 
A lot has been discussed about the rising
prevalence of obesity even among developing
countries and its association with other co
morbidities. (1).Childhood overweight and obesity
is emerging as global epidemic and has become
a major public health concern (2). The developing
countries too are not spared and the burden of
obesity disproportionately affects the Indian
population. For instance, overweight and obesity
is more in urban areas and is especially more
among affluent class (3). The changing lifestyle
and eating habits due to urbanization have lead
to an increase in obesity among children and
adolescents in India (4). It is inextricably linked
to the surrounding environmental, behavioural
and cultural aspects. There is an uptrend in
urbanization in India resulting in increased
purchase power and shift in lifestyle more
towards sedentary kind besides increased
consumption of calorie dense food. The children
are exposed to many risk factors of overweight
and obesity early in life, without realizing the
health hazards in later life.
Excess body fat in children and
adolescents have been found to be the cause for
many clinical and biochemical abnormalities like
insulin resistance, dyslipidemia, high leptin and
high blood pressure all of which act as a trigger
for the development of type 2 diabetes and
cardiovascular diseases in adulthood (5-12). Since
type 2 diabetes among Indians have reached
epidemic proportions (13), it is imperative that
children and adolescents are aware of its risk
factors like family history, obesity sedentary
lifestyle and unhealthy eating habits.
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Research from our country suggests that
the awareness on diabetes is inadequate among
the general population aged more than 20 years
(14). But there is virtually no data from India
assessing awareness levels of diabetes and
obesity among children and young adults.
Understanding the behavioral patterns, the
knowledge and awareness levels of the younger
generation are important in planning
intervention programmes. The aim of this study
was to measure the awareness levels of children
on obesity, their attitude and practices.
	

A total of 1266 (M:F, 673:593) school
children from 8 to 16 years (IV grade to X grade),
selected by stratified cluster sampling technique
were interviewed by administering a well
designed and validated proforma by trained
research officers. To have a representative study
sample, 2 private schools and 1 corporation
school (government aided) were included in the
study. Generally, private schools which have a
higher fee structure mostly admit children from
affluent society, while corporation schools were
attended by children from low socioeconomic
status. The study protocol was approved by the
ethics committee of the institution.
The questionnaire was interviewer
administered to the children of classes IV to X
after getting permission and written consent from
the school principals. Anthropometric
measurements were recorded before
administering the questionnaire. The instrument
contained 3 parts- a) General characteristics b)
anthropometric measurements – height, weight
and waist circumference. c) Questions on
knowledge related to diabetes, obesity,
behavioural practices of children pertaining to
diet, physical activity and TV watching.
The percentage of respondents who gave
the correct answers to each question was
assessed for total survey sample. Correct answers
were awarded marks and total scores for
knowledge and awareness were computed. The
total attainable maximum knowledge score was
8. The scores obtained by the children were then
compared with age, socioeconomic status and
gender. Chi square / z test was done as
appropriate to determine the significance testing
between groups. A p value <0.05 was considered
as significant.


The comparative mean scores attained by
children on knowledge of obesity and its risk
factors are shown in Table 1. Highly significant
differences in knowledge scores were seen among
the children with respect to age, gender and socio
economic status. Higher scores were obtained by
children aged 13 years and older, female gender
and children from high socioeconomic status
(p<0.0001). The 50th percentile for low
socioeconomic status fell on score 3 whereas it
was on score 5 for high socio economic status.
Percentage of children scoring the least (score 0)
and highest (score 8) were 5.2 and 2.4% among
low socioeconomic status and 0.5 and 7.6% for
high socioeconomic status children. The children
had poor knowledge on obesity, only 32% of the
them knew what obesity is. Even though 63.1 %
of the study population was aware about
diabetes, only 34.8 % knew that it could be
prevented.
Table 1: Knowledge scores according to age, gender and socioeconomic status.
  	
  	 	   	  
Age: (years) 8-12 702 (55.5) 3.6 1.9 <0.0001
13-16 564 (44.5) 5.2 1.8
Gender: Male 673 (53.2) 3.9 1.8 <0.0001
Female 593 (46.8) 4.8 2.2
SES: HSES 976 (77.1) 4.6 1.9 <0.0001
LSES 290 (22.9) 3.1 1.9
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Table 2 shows details of knowledge on
individual questions and the percentage of correct
answers among children based on socioeconomic
status. About 82 % of the adolescents (>=13
years) have heard of diabetes. However the
knowledge on prevention of diabetes was low
among all the study subjects. There was
generally a low level of awareness on obesity.
The children had poor knowledge about balanced
healthy diet while junk foods and its ill effects
were better known only to affluent children.
Socioeconomic status had a significant impact on
the level of awareness among children for all the
knowledge based questions 1-7(p<0.0001).
The knowledge scores, attitudes and
practices related to diet and physical activity
were assessed and are shown in table 3 stratified
according to weight.
Table 2: Awareness levels according to socioeconomic status.
Variables LSES HSES
8-12 years
n=177
13-16 years
n=113
8-12 years
n=525
13-16 years
n=451
1. Heard of diabetes: yes 62
(35.0)
92
(81.4)
274
(52.2)**
375
(83.1)
2. Can diabetes be prevented: yes 11
(6.2)
51
(45.1)
158
(30.1)*
221
(49.0)
3. Heard of obesity :yes 21
(11.9)
62
(54.9)
125
(23.8)**
196
(43.5)**
4. Know about balanced diet: yes 14
(7.9)
32
(28.3)
204
(38.9)**
225
(49.9)** 
5. Know about junk food: yes 18
(10.2)
48
(42.5)
305
(58.1)**
377
(83.6)**
6. Does physical activity promote good health: yes 117
(66.1)
90
(79.6)
471
(89.7)**
418
(92.7) **
7. What is ideal body size? 120
(67.8)
95
(84.1)
352
(67.0)
374
(83.0)
χ2 test done between similar age groups of two socio economic groups
* p value <0.05, ** p<0.0001
Table – 3 Descriptive details of attitude and practices among normal, overweight and obese children.
Normal Overweight Obese
985 (77.8) 172 (13.6) 109 (8.6)
(i) Knowledge score
Mean (sd) 4.2 (2.0) 4.9 (2.0) 4.5 (2.0)
(ii) Attitude
What will you do if you know that junk foods are harmful?
   (i) Avoid eating 270 (27.5) 59 (34.3) 32 (29.4)
   (ii) Eat less 621 (63.0) 98 (57.0) 70 (64.2)
   (iii) Will continue to eat 92 (9.3) 15 (8.7) 7 (6.4)
(iii) Practices
Atleast 60 mins of daily physical activity 398 (40.4) 59 (34.3) 33 (30.3)
Consumption of Fried food upto 2 times per week 615 (62.4) 125 (72.7) 78 (71.6)
Fast food  Upto 2 times per week 535 (54.3) 83 (48) 52 (48)
Eating out Upto 2 times per week 507 (51.5) 79 (46) 57 (52.3)
Values are shown as number (%)
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Normal ≥ 50th - < 85th Percentile
Overweight ≥ 85th – < 97th percentile
Obesity ≥ 97th percentile
(WHO BMI for age percentile charts 2007 are used
as reference)
Discussion
To the best of our knowledge the
awareness level of obesity and diabetes, its
related lifestyle practices and behaviour among
children and adolescents was being assessed for
the first time in Chennai by this study. The
present study showed that the level of knowledge
and awareness on the above factors was however
low and highly influenced by socioeconomic status
(p<0.0001), hence confirming the existence of
intra - urban differences in the awareness levels.
Children and adolescents of higher socioeconomic
status and those attending the private school had
better knowledge than their counterparts from
corporation school. It was observed from the
study that the children were well informed about
the good effects of physical activity but were not
engaged in daily physical activity. Only 34 % of
the over weight and 30% of the obese children
were engaged in atleast 60 minutes of daily
physical activity, which is suggestive of the
sedentary kind of lifestyle of the younger
generation. Prevention is the topic of interest
today in order to control this escalating
prevalence of obesity. Hence focus must be made
on spreading awareness on the preventive
aspects of the disease targeting not only children
as audience but also involve the parents and
teachers.
Chennai is a metropolitan city in India
which has experienced rapid urbanization in last
two decades. Rapid epidemiological transition is
currently sweeping across India, making the
urban and peri urban areas more urbanized in
terms of economy and luxury. This has a direct
impact on food habits and lifestyle. Springing up
of international standard fast food outlets and
food zones are a major attraction to the
adolescents and young adult population. Eating
habits of the children from this study showed
that there was widespread prevalence of
consumption of fried food and fast food items and
the children frequently dined out. An urban
Indian adolescent usually consumed less of fruits,
and greens, but more of industrialized snacks,
sweets, savouries and cool drinks in replacement
of breakfast and even lunch. These calories dense
but zero nutritive value foods are causes of
adiposity which in turn lead to cycle of events.
To summarize, the current study has
shown that knowledge among the children on
obesity and its effects is inadequate. The
persistence of unhealthy practices among the
children must be given attention. This study has
thus highlighted the need to not only improve
the awareness on prevention of childhood obesity
among children but a need to motivate and
reinforce them to practice healthy lifestyle is
utmost essential.
Old habits die hard, hence the root of non
communicable diseases – overweight and obesity
must be tackled at an early age. This can be
done effectively by education and awareness
creation. Not only must awareness be created,
but the children need to be motivated to practice
healthy habits, as we understand from this study
that even though the children were aware about
the good effects of physical activity on health,
very few played out door games daily. Certain
guidelines and policies like school canteen policy,
healthy food practices, inclusion of health related
topics in curriculum and compulsory physical
training classes must be introduced in the
schools. There must be a multi sector approach
from the government, school authorities and
parents to introduce policies and guidelines to
curb on the obesity menace and to help today’s
children to live a long healthy life tomorrow.
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Case Report
Polymerase Chain Reaction – Breaks the Dilemma in Meningitis
Dr Ilavarasi Lakshmanan., Dr Yeldho Eason Varghese, Dr Naveen Mohandas., Dr Mohini Singh.,
Dr R.B. Sudagar Singh., Prof. J.Damodharan
Abstract
Tuberculosis continues to be a major cause
of morbidity and mortality in developed and
developing countries, despite the availability of
effective chemotherapy. Despite its global
importance, the diagnosis of extra- pulmonary
tuberculosis (EPTB) remains an important
clinical problem, primarily because of inadequate
sensitivity of conventional bacteriologic methods
for detecting Mycobacterium tuberculosis in extra
pulmonary specimens. In this case report, a 45
year old female diabetic, hypertension, also a
known case of Progressive systemic sclerosis,
presented with fever, altered behaviour and
drowsiness. Lab investigations showed normal
blood routine, RFT & LFT. CSF analysis revealed
only elevated proteins. CT brain done on the day
of admission was normal and later repeated as
the patient developed left facial palsy and lateral
rectus palsy, which revealed communicating
hydrocephalus. CSF was sent for Polymerase
Chain Reaction for TB, which was reported as
positive for Mycobacterium tuberculosis using
IS6110 primer. Following treatment with ATT
and steroids the patient has shown significant
improvement and is symptom free after nine
months of treatment with ATT. We recommend
that CSF specimens be submitted for PCR testing
whenever CSF analysis is inconclusive and
clinical suspicion is sufficiently high to warrant
empiric ATT therapy and conventional
bacteriologic methods are negative.
Key Words: Extra- pulmonary tuberculosis, PCR,
M. tuberculosis.
Introduction:
Tuberculosis is a rampant disease in
developing countries such as India where the
prevalence is reported to be high. In countries
with a high incidence of tuberculosis,
tuberculosis meningitis is typically a disease of
young children that develops three to six months
after primary infection. In countries with a
low incidence of tuberculosis, tuberculosis
meningitis more commonly affects adults, and
although it may follow primary infection, it more
frequently arises from the reactivation of a
dormant sub cortical or meningeal focus. The
diagnosis of extra-pulmonary tuberculosis in its
different clinical presentation remains a true
challenge. The disease’s underestimation by
clinicians and the use of insensitive conventional
analytical methods have contributed to the
difficulties in managing patients with EPTB.
Early recognition of TB meningitis is of
paramount importance because the clinical
outcome depends greatly upon the stage at which
therapy is initiated Thus the implementation of
diagnostic methods with high specificity and
sensitivity would improve the clinical outcomes
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for EPTB patient’s and should accelerate the
application of appropriate public health control
measures.
Case Report:
A 45 year old female, who was a known
diabetic and hypertensive on treatment, also a
known case of Progressive systemic sclerosis on
treatment with steroids and pulse
cyclophosphamide therapy; presented to
emergency with history of fever of 1 week
duration, which was intermittent and low grade,
altered behaviour and drowsiness of 1 day
duration. On examination she was drowsy but
arousable, febrile, had a pulse rate of 96/min,
respiratory rate of 24/min, and BP of 130/70 mm
of Hg. She had glossitis and stiffening of skin
over face and mouth. Patient did not have signs
of meningeal irritation. Examination of other
systems showed no abnormalities.
Lab investigations revealed a hemoglobin
of 12.4gm/dl, total count of 10,910 cells/cu.mm,
with polymorphs of 78.8%, normal platelets and
ESR was 52 at one hour. RFT, LFT and
coagulation profile was within normal limits and
peripheral smear and QBC was negative for
malaria parasites. In view of fever with altered
sensorium lumbar puncture was done under
strict aseptic precautions on the same day. CSF
study revealed elevated proteins of 143 with
normal sugar and chloride and no cells. CSF
gram stain was negative and AFB stain was also
negative. CSF culture was sterile for bacteria and
fungi (table 1).
Table 1:
Parameters Values
Hb 12.4g/dl
TC 10,910 cumm
Platelets 3.12 lakhs/cumm
ESR 52 at one hour
PT/ PTT / INR 15.5 seconds / 30.8 seconds / 1.14
LFT-
Total bilirubin / Direct bilirubin 0.48 / 0.14 mg/dl
SGOT/SGPT 18 / 23 U/L
Alk. Phosphatase 75 U/L
Total proteins 7.4 g/dl
Albumin/globulin 3.8 / 3.6 g/dl
CSF-Proteins 143mg/dl
Sugar 40 mg/dl
Chloride 106
WBCs Nil
RBCs Nil
CSF Culture No growth
India ink preparation Negative for capsulated organism.
RFT
BUN / Creatinine 10 / 0.9 mg/dl
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CT brain done on the day of admission did
not reveal any significant abnormality (figure 1;
table 2).
Figure 1
Table 2
CT –Brain is normal on the day of admission.
During the course in the hospital the
patient developed left facial palsy and lateral
rectus palsy. Patient required mechanical
ventilation in view of low GCS on the fourth day
of admission. CSF study was repeated which
showed a rise in protein levels to 182 with
normal sugar & chloride and absence of cells.
CSF was sent for Polymerase Chain Reaction for
TB. Patient was started on ATT and steroids on
the same day. CT scan was also repeated which
showed communicating hydrocephalus (figure 2;
table 3). PCR test was reported as positive for
Mycobacterium tuberculosis using IS6110 primer
(figure 3; table 4).
Figure 2
Table 3
CT - Brain shows communicating hydrocephalus.
Figure 3
Lane 2: CSF
Lane 3 & 5 Other samples
Lane 4: CSF
Lane 6: Positive control
Lane 7: Reagent control
Table 4
PCR test is positive for Mycobacterium tuberculosis
using IS6110 primer
Patient’s condition slowly improved and
was weaned off mechanical ventilation by tenth
day of admission. Subsequently patient was
shifted to ward on the fourteenth day. Patient
continued to have left facial and lateral rectus
palsy at the time of discharge (the twentieth day
after admission). Patient was followed up second
weekly thereafter and was completely symptom
free after nine months of treatment with ATT
She also recovered from the lateral rectus palsy.
A repeat CT scan done after nine months was
normal (figure 4; table 5).
Figure 4
Table 5
CT- Brain is normal on follow up
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Discussion
Tuberculosis is a protean disease affecting
virtually all the organs and has a wide spectrum
of clinical presentation depending on the
anatomical site involved. TB meningitis is a
challenge for clinicians because of the difficulty
in making an early diagnosis and the severe
consequences of delaying the treatment. Thus
early recognition of TB meningitis is of
paramount importance because the clinical
outcome depends greatly upon the stage at which
therapy is initiated. The diagnosis of extra –
pulmonary tuberculosis remains an important
clinical problem, primarily because of inadequate
sensitivity of conventional bacteriological methods
for detecting Mycobacterium tuberculosis in extra
– pulmonary specimens.
PCR–based assays using the insertion–like
sequence elements IS6110 are rapid and sensitive
and has modified strategies for the detection of
Mycobacterium tuberculosis.(1,2) Nucleic acid
amplification can be utilized to identify
tuberculosis infection in diverse clinical
specimens including CSF, pleural fluid, ascitic
fluid, urine and pericardial fluid. (1, 6, 7, 8)
PCR assay is more sensitive than the
conventional methods, especially when low
numbers of bacilli are present. Antibiotic therapy
rapidly lowers the number of viable infecting
bacilli and decreases the likelihood that culture
assays are positive. However, as amplification
methods can detect dead bacteria, the PCR assay
remains positive until the killed bacilli are
cleared. PCR has several advantages over
culture, including confirmation of the presence of
M. tuberculosis within 1 to 3 days as compared
to 6 weeks with conventional culture techniques.
DNA amplification can be used for tissue
specimens which are already formalin – fixed and
paraffin-embedded. (1, 3, 9) Furthermore,
patients are often given treatment for EPTB
based only on clinical suspicion, as treatment
delays can negatively impact clinical
outcomes.(8,12) PCR perhaps, is a highly
sensitive technique that detects DNA from a
single to few micro-organisms with overall
sensitivity, specificity and positive predictive
value of 97.87%, 100%,and 100% respectively (3).
Conclusion
PCR is a rapid method for detection of
mycobacterium tuberculosis especially extra-
pulmonary tuberculosis. Several studies have
reported the usefulness of PCR using IS6100
primer to detect mycobacterium tuberculosis.
With low reliability of the conventional
techniques, implementation of more sensitive
methods should be encouraged for specimens
suspected to have few bacilli.
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Review Article
Medical Management of Renal Stone Disease
Dr. P.Soundararajan
Management of stone disease has changed
from exclusively surgical management for stone
removal to medical management to prevent stone
occurrence and recurrence but also to facilitate
dissolution or safe passage of stones in many
clinical situations. Physicians and primary care
providers should assume greater responsibility
for long term stone management programmes
and restrict select referrals to surgeons whenever
necessary. Medical management is not only
restricted to increased fluid intake but also to
carryout investigations to find out the etiology of
stones in every case and to prescribe suitable
drugs and diet when required and to periodically
check the effectiveness of drugs and diet by
specific laboratory tests to avoid stone recurrence
. Taking into consideration the high incidence of
recurrence surgical treatment of urinary stones
is an incomplete procedure. The goal of surgical
treatment is the removal of existing stones while
that of medical treatment is the prevention of
recurrent stones formation. Continued application
of medical and surgical approaches is mandatory
for the full control of the disease. Stone disease
management today involves huge financial
burden on the patient care. Hence treating
primary physicians need to play pivotal role in
choosing appropriate investigations and selective
mode of therapy in every stone patient in a cost
effective manner.
Renal stone disease secrets
Primary physicians need to understand
that most of the stones encountered in day today
practice belong to the category of small stones
less than 8 mm to 10 mm mostly in the collecting
system which can be delivered by medical
measures alone.
Renal stone disease is a medical disease
with surgical complications and consequences.
Mechanisms of stone formation underlies
abnormal urinary composition arising out of
defective nephronal function involving excess
glomerular filtration and are defective tubular
secretion or reabsorption. To every patient one
should ask oneself why stones form in a
particular patient to get etiological clue to
prevent stone recurrence in future. In case of
untreated calcium oxalate stone the chance of
recurrence is 10 % in one year, 35 % in 5 years,
and 50% in 10 years.
Medical management consists of four parts
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Renal stone disease by itself is not a
sufficient diagnosis as much as the term edema
or ascites or fever means, etiological diagnosis is
mandatory for effective management.
Clinical Evaluation
Acute renal colic is the most common
presentation, pain does not completely remit
rather waxes and wanes and the location of
stones modifies the pattern of pain. Nausea,
vomiting may accompany. Rarely gross hematuria
occurs without pain. Urethral stones can mimic
gall stone, appendicitis, cystitis, pelvic organ
pathology in females. Other conditions to consider
as differential diagnosis are musculoskeletal pain,
herpes, duodenal ulcer, abdominal aneurysm,
gynec causes, and urethral obstruction due to
blood clot, sloft papillae and urethral stricture.
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Laboratory Investigations and Imaging
Studies
For evaluation of kidney stone how much
to be done and to what extent depends on several
variables. First, what is the stone burden? First
time stone former or recurrence stone former?
Following points merit consideration, total
number of stones, types of previous procedures
and their success, residual stones, family history
of stones , diet details and medication usage
before the stone event . Because of non specific
physical findings, laboratory findings and
imaging studies play a crucial role in making the
diagnosis. Helical spiral CT is the modality of
choice because it does not need contrast agent
and can detect stones as small as 10mm, even
in uric acid stones traditionally considered
radiolucent, ultrasonography can image only the
kidney and proximal ureters. A plain X ray KUB
can miss a stone in ureters or kidney even one
that is radio opaque and provides no information
on obstruction. X-ray KUB is used to locate
urethral stone or growth of asymptomatic kidney
stones and its sensitivity is limited. IVP requires
contrast and can miss small stones. It is ordered
less frequently now a day in tertiary care centers.
Dietary Modifications
All patients with stone disease are advised
to follow strict dietary modification irrespective
of their normal investigations many times.
High fluid intake: Patient is informed to
measure urine out put once a week and then
adjust the fluid intake to maintain urine output
more than two litres/day. they are also advised
to take maximum intake of fluid with in three
hours after taking the meals, during periods of
physical exercise, bedtime and once at midnight,
plain water is good enough but potassium rich
citrus fruit juices such as orange, grape fruit and
berry are preferable to low potassium citrus
fruits such as lime and lemon, orange juice for
example represents a natural form of potassium
citrate and posses alkalizing and Citra uric
action 48. Limejuice, on the other hand, is
composed largely of citric acid, and does not
affect acid base balance appreciably, so it does
not alter urinary PH and only modestly increases
urinary citrate 49.Increasing fluid intake actually
has been demonstrated to have positive effect on
two urinary inhibitors, citrate and Tomm-Horsfall
protein. Hydration augments urinary citrate
excretion, which is thought to result from an
increased fluid flux in the proximal tubule
resulting in the delivery of more bicarbonate to
the cells of this portion of the nephrons .Urinary
dilution has been found to increase the inhibitory
activity of Tomm-Horsfall protein on the calcium
oxalate monohydrate crystal aggregation in the
urine of the stone formers.
  
  
Patient is informed to avoid
non-vegetarian diet and the recommendation is
of 8 oz or less of dry meat/day animal proteins
are rich sulphur containing amino acids such as
cystine and methionine, which on oxidation
produces sulphate which forms a soluble complex
with calcium in the nephron and limits the
reabsorption of this cat ion, bone serves as a
buffer and the resultant osseous dissolution
provides more calcium to be excreted, chronic
metabolic acidosis decreases calcium reabsorption
with in the nephron, which further augments
excretion of this mineral, increased protein
consumption also augments glomerular filtrations
, thus delivering more calcium to the nephron
which promotes its excretion. Animal protein as
a high purine content, which leads to increase
in uric acid excretion. The associated acidosis
resulted in a decrease urinary PH that could
potential uric acid urolithiasis. Acidosis also
enhances citrate reabsorption in the proximal
tubule and thus decreases excretion of citrate in
the urine.
  
Patient is asked to avoid high sodium
containing food with restriction of salt in the diet
and salty shakers. Increased sodium intake may
promote a variety of metabolic changes that may
be detrimental to stone formers, including
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increase in the urinary PH, calcium and cystine
excretion and a decrease in citrate excretion.
  
Avoidance of nuts, spinachs,dark
roughage,chocalate,tea, and vitamin C and
advised to maintain recommended daily intake of
calcium and to ensure that calcium consumption
accompanies the ingestion of oxalate rich foods
to prevent the absorption of oxalate.
  
 
Moderate restriction of calcium is
recommended and about 250ml of milk or milk
products can be taken daily .in patients who are
advised for long-term restriction of calcium
intake, measurement of bone density, particularly
in the spine is recommended.
Dietary Recommendation Role
Urinary
Abnormality 
Dietary Changes Medication
High calcium
concentration
Avoid excessive
intake of calcium
supplements
Thiazide
Maintain adequate
dietary calcium
intake 
Reduce intake of
animal protein 
Reduce sodium
intake to < 3g/day
Reduce sucrose
intake 
High oxalate
concentration
Avoid high oxalate
foods
Maintain adequate
dietary calcium
intake
High dose
pyridoxine?
Avoids vitamin C
supplements
High uric acid
concentration
Reduce purine
intake (i.e.
meat, chicken,
fish)
Low citrate
concentration
Increase intake of
fruits and
vegetables
Alkali (e.g. K
Citrate)
Reduce intake of
animal protein
Low volume Increase total fluid
intake
Not applicable
Calcium
Contrary to the popular belief there is no
evidence that dietary calcium restriction is
helpful in preventing stone formation and there
is substantial evidence that routine calcium
restriction is harmful, recent studies support the
concept that dietary calcium intake is inversely
associated with risk of stone formation.
Mechanism by dietary calcium reduce stone risk
is by calcium binding to oxalate in intestine there
by blocking oxalate absorption.
The role of calcium supplement deserves
comment because their use is common if someone
who never had a stone the risk attributed to
supplement is low. For a patient who had a
calcium stone and wishes to continue taking
calcium supplements 24hrs urine chemistry
should be checked while the patients is taking
and not taking supplements and advised
accordingly. Decreasing intake of animal protein
(meat, chicken, and sea foods) may be helpful.
Difference in timing of ingestion may
explain the apparent contradiction between the
protective effect of dietary calcium and
detrimental effect of supplemental calcium. A
protective effect would not be expected unless
calcium supplements are taken with meals
containing oxalate. A reported risk of
supplemental calcium intake is a result of
increased urinary calcium excretion without any
change in oxalate excretion.
Patients who have low citrate in the urine
should increase their intake of potential alkali
(fruits and vegetables) and decrease intake of
acid producing foods such as animal protein. For
patients with high urine oxalate levels the
benefit of low oxalate diet is less clear. Many
foods contains only small amounts of oxalate but
food that are high in oxalate are less common.
An increase in calcium in diet may reduce
oxalate absorption and thereby reduce urinary
oxalate excretion.
TAPI Journal Vol 2, Issue 1, January - April 2010
31
I Pharmacological options:
When to use medications? If dietary
modifications are unsuccessful in adequately
modifying the urinary, drug therapy is indicated
to achieve the same.
Drugs used in stone prevention are
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Thiazide
For patients who have elevated calcium
levels do not have an exceed calcium intake (not
more than 1500 mg per day) Thiazides are shown
to reduce stone recurrence while maintaining
bone density with no risk of osteoporosis. Dosage
required to reduce urine calcium excretion
substantially higher than those used for
treatment of hypertension (at least 25 mg per
day and often 50 mg per day to 100 mg per day)
randomised controlled trials have confirmed a
50% reduction risk of stone recurrence. Adequate
sodium restriction (less than 3 gm per day is
heavy to achieve, a higher sodium intakes leads
to greater distal sodium delivery which minimizes
or regulates the beneficial effect of thiazide. For
patients who are unable to increase their fluid
intake, thiazide may be helpful to increase in
urine where it will reduce urine calcium
concentration. Can we deliver stone by medical
measures?
It depends on size of the stones and site
of stone, whether obstructing or non obstructing
the urethral passage. Stones less than 6 mm are
likely to pass out through urine. Over 8 mm are
unlikely stones in the distal ureters are more
likely to come out than the in proximal ureters
with the kidneys
II Pharmacological option for drugs to
facilitate stone passage - called “MEDICAL
EXPLOSIVE THERAPY”
Researchres recently have sought out
pharmacologic means of increasing rates of stone
passage and reducing both surgical intervention
and financial costs. The use of hormones , non
steroidal anti inflammatory drugs (NSAIDS) ,
calcium channel blockers , corticosteroids , and
adrenergic alpha antagonist all have been
proposed as a way to enhance stone passage.
Hormones, Progesterone
Numerous laboratory, as well as clinical
studies has shown that sex hormones have a
dilatory effect on the urinary tract, suggesting a
possible therapeutic role for hormones in
facilitating stone passage. Progesterone has been
one of the most studied hormones. Progesterone
is believed to cause dilation of the ureters by
acting on the beta adrenergic receptors. It also
as been shown to decrease the muscular activity
of the ureters. Mikkelsen et al further studied
this drug in a non randomized study of 24
patients with a ureters calculi. All patients were
given intra muscular injection of 250 mg of
hydroxyl progesterone and followed up until stone
passage or surgical intervention. In all, 14 of 24
patients (59%) were able to pass their stone
spontaneously, which is much higher than the
previously reported rates for spontaneous stone
discharge (18 % - 39 %). no side effects of
hydroxyprogesterone were observed in any
patient. The investigators concluded that
hydroxyprogesterone treatment is simple,
inexpensive, and is without side effects.
Glucagon
Glucagon is a well described smooth
muscle relaxant of the gastro intestinal system.
The actions of the glucagons on the urinary tract
are not as well defined. In vitro and in vivo
canine studies have shown that glucagons causes
brief cessation of ureteral peristalsis. Lowman et
al first published a preliminary report in 1977
describing 10 patients with ureteral calculi who
were given one mg of intravenous glucagon. 3
patients had spontaneous passage of their stone
in 4-8 hours. No side effects of the medication
were reported. At this point at time, although
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glucagon has proven effects to the urinary tract,
expulsive therapy for urolithiasis remains largely
untested.
NSAIDS
Prostaglandins impede ureteral stone
passage through several interrelated mechanism.
Prostaglandins are generated from arachidonic
acid via cyclooxgenase (COX) activity. The 2
isoforms of COX are COX1 and COX 2. The
studies of ureteral contractility have shown that
prostaglandin F2 alpha and prostaglandins E2
increase contractility in obstructive ureters and
that indomethacin (non specific inhibitor of COX)
can inhibit generation of these contractions.
Besides alteration in contractility, NSAIDS also
treat renal colic by blocking the local release of
pain – mediating prostaglandins.
Indomethacin
Al- walli first conducted the open study
investigating the effect of indomethacin
suppositories on both acute urinary colic and
expulsion rates of stones resistance to
convulsional analgesics and anti spasmodic.
Diclofenac Sodium
Diclofenac sodium has been studied in two
clinical trials to date.
Calcium Channel Blockers
The primary anatomic unit of the ureters
is the smooth – muscle cell, which functions in
response to changes in calcium ion concentration.
An increase in calcium concentration causes
contraction. Conversely, a decrease in calcium
concentration results in relaxation.
Nifedipine
Six studies evaluating nifedipine as a
medical expulsive therapy have been reported to
date. Borghi et al conducted the first randomized,
double – blind, controlled trial using nifedipine.
Adrenergic Alpha Antagonist
Alpha receptor antagonists have long been
used to treat symptoms of benign prostatic
hypertrophy and prostatitis. Their mechanism is
via smooth-muscle relaxation of the prostate and
bladder neck via inhibition of alpha 1a receptors,
resulting in increased urinary flow. Tamulosin is
uro selective for the alpha 1a and alpha 1d
receptors, resulting in an overall lower side effect
profile compared with the non selective agents.
In the ureters, alpha 1 adrenergic receptor
antagonists inhibit basal tone and also decrease
peristaltic frequency and amplitude.
Consequently, intra ureteral pressure decreases
and fluid transport increase. Given its receptor
specificity and vitro findings, its seems plausible
that tamulosin would be useful in the treatment
of obstructive ureteral calculi.
Tamulosin
Several clinical trials have shown that
alpha 1 blockers not only are useful for stone
expulsion, but for control of stone colic as well.
Tamulosin versus Nifedipine
Recently, Hollingsworth et al provided
further validation by reporting a Meta –analysis
assessing the efficacy of drug therapy in
facilitating spontaneous passage of ureteral
stones. They also concluded that the addition of
corticosteroids might have a small advantage, but
the benefit of drug therapy is not lost in those
patients in whom corticosteroids might be
contraindicated.
Multiple clinical trials have shown that
tamulosin improves stone passage rates,
decreases stone – expulsion times, and reduces
the need for analgesic therapy, hospitalization,
and surgery. The non selective adrenergic alpha
blockers also appear to be effective as well.
Medical expulsive therapy for ureteral
stone provides other non surgical options for
patients with ureteral stones. Multiple
randomized clinical trials have shown that
medical expulsive therapy is clinically efficacious,
safe, and will tolerate.
Conclusion
The medical management of urolithiasis is
a rational approach based on the abnormal
TAPI Journal Vol 2, Issue 1, January - April 2010
33
parameters detected on full investigations.
However, in clinical practice it is very difficult
as the patient may have all normal urinary
parameters or multiple deranged parameters.
In patients with all normal urinary
parameters (idiopathic) the patient is advised for
the dietary restriction and kept on periodic
surveillance. In patients with multiple deranged
parameters the drug approach in a permutation
combination rationale is applied with periodic
surveillance of the parameters at repeated
intervals for the dose modification or temporary
discontinuation of the drug therapy. Both
surgical and medical treatment is necessary for
the complete management of patients of
urolithiasis.
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Abstract
Here we report the case of a 48-year-old
female patient admitted with exertional
breathlessness and easy fatiguibility. She was
diagnosed as having severe autoimmune
hemolytic anemia (AIHA) with autoimmune
thrombocytopenia (Evans Syndrome) and was
found to have coexisting Hashimoto’s thyroiditis.
We prescribed prednisolone and thyroxine
administration. Hashimoto’s thyroiditis is often
associated with other non endocrine autoimmune
diseases. However, there is no report of Evans’
syndrome co-existing in patients with overt
hypothyroidism and Hashimoto’s thyroiditis, and
thus is the first such reported case from India.
Introduction
Chronic, autoimmune thyroid diseases are
sometimes combined with autoimmune
hematologic diseases, such as pernicious anemia,
autoimmune hemolytic anemia (AIHA) and
idiopathic thrombocytopenic purpura (ITP).
Hashimoto’s thyroiditis is one of the most
common autoimmune diseases. It is due
to autoantibody formation and lymphocyte
infiltration of the thyroid glands. Since Evans
reported the first case of AIHA associated with
ITP, there have been several case reports of
Evans’ syndrome occurring simultaneously with
an autoimmune thyroid disease (1) ,nine cases of
Evans’ syndrome occurring with Graves’ disease
have been reported(2)(3),(4), and two case of Evans’
syndrome with Hashimoto’s thyroiditis and
hypothyroidism has been reported
worldwide(5).Here we report a case of Evans’
syndrome developed together with Hashimoto’s
thyroiditis and overt hypothyroidism in a
48-year-old woman.
Case report
A 48 year old female was admitted with
complaints of giddiness and exertional dyspnea
for 1 month. There is no history of palpitations
and chest pain. She did not have any history of
hypertension and diabetes. General examination
revealed pallor, icterus and thyroid enlargement.
On abdomen examination showed 3 cm
hepatomegaly, splenomegaly .Examination of
other systems were within normal limits. On
evaluation she had an Hb of 3.8gm%, platelet
count of 3,000/mm3., TC: 10,300. Reticulocyte
count was 4%.ESR was 40mm of mm/1st hr.
Urine analysis showed urobilinogen positivity.
S.bilirubin was 4.1mg %. (direct: 1.6, indirect2.
5).SGOT and SGPT were within normal limits.
Peripheral smear showed anisopoikilocytosis,
polychromasia with thrombocytopenia. Bone
marrow aspirate showed erythroid hyperplasia.
USG Abdomen revealed hepatosplenomegaly. A
clinical diagnosis of hemolytic anemia with
thrombocytopenia was made. ANA, HIV ELISA
was negative. X-ray chest showed cardiomegaly.
As neither platelet count nor hemoglobin
increased with repeated blood transfusions,
autoimmune lysis was suspected. Hence Coombs
test was ordered. Coombs test (direct) was
positive. Hence the autoimmune etiology was
proved and a diagnosis of Evans syndrome was
made. Since the patient had a thyroid
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enlargement, thyroid function test was done.
Thyroid function test showed low T3,T4 and high
TSH consistent with hypothyroidism. Since an
autoimmune disease already was established by
positive Coombs test, cause of hypothyroidism
was also suspected to be autoimmune. Hence,
Anti Microsomal antibody (thyroid) was done,
which was strongly positive (>600,
normal<34).There was difficulty in determining
blood grouping due to auto agglutination.
Hemoglobin as well as platelet count failed to
improve with blood transfusions. Patient was
started on oral steroids- prednisolone 1mg/kg and
Eltroxin 100 micrograms. After 10 days of
treatment, Hb improved to 5.6 gm%, and platelet
count showed marginal improvement to 9,000.She
did not have any external bleeding. Patient was
discharged on oral steroids and Eltroxin.
Discussion
Hashimotos thyroiditis (or Hashimoto’s
thyroiditis) is part of the spectrum of
autoimmune thyroid diseases. Hashimoto’s
thyroiditis is characterized by the destruction of
thyroid cells by various cell- and
antibody-mediated immune processes. Patients
with Hashimoto’s thyroiditis have antibodies to
various thyroid antigens, the most frequently
detected of which include anti – thyroid
peroxidase (anti-TPO), antithyroglobulin
(anti-Tg), and to a lesser extent, TSH
receptor-blocking antibodies. Nevertheless, a
small percentage of patients with Hashimoto’s
thyroiditis (approximately 10-15%) may be
antibody negative. The most common and early
presenting symptoms of hypothyroidism, such as
fatigue, constipation, dry skin, and weight gain,
are nonspecific. In the presence of suggestive
symptoms and physical findings, a serum TSH
test is needed for the diagnosis of primary
hypothyroidism, and it serves to assess the
functional status of the thyroid. The presence of
thyroid autoantibodies, typically anti-TPO and
also anti-Tg antibodies, delineates the cause of
hypothyroidism as Hashimoto’s thyroiditis or its
variant. The treatment of choice for Hashimoto’s
thyroiditis (or hypothyroidism of any cause) is
thyroid hormone replacement. The drug of choice
is orally administered levothyroxine sodium,
usually for life.
Evans syndrome is a combination of
immune thrombocytopenia and autoimmune
hemolytic anemia (AIHA). Evans syndrome is a
diagnosis of exclusion. Confounding disorders,
such as infections, rheumatologic diseases, and
malignancies can present with autoimmune
cytopenias, must be ruled out. Autoantibodies are
directed against antigens specific to red cells,
platelets or neutrophils. In Evans syndrome, the
direct antiglobulin result (i. e, Coombs test
result) is almost invariably positive (often
weakly) and may be positive for IgG,
complement, or both. Indirect antiglobulin test
findings may also be positive in 52-83% of
patients. Prednisone therapy, the most commonly
used first-line therapy, often effectively controls
acute episodes, although relapses may be
frequent when patients are weaned off
prednisone. Other therapies effective in small
series include danazol, cyclosporine, azathioprine,
cyclophosphamide, and vincristine. Splenectomy
may improve CBC counts and decrease the
steroid requirement, although relapses are
common. Hashimoto’s thyroiditis and Evans’
syndrome are autoimmune disorders. Yet the
combined disorders have still not been classified
in Autoimmune polyglandular syndromes (APS).
There are two distinct types of autoimmune
polyendocrine syndromes with characteristic
clinical manifestations. APS (autoimmune
polyendocrine syndrome) type I, typically
recognized in early childhood, is a rare
autosomal, recessive disorder. Defects in the
autoimmune regulator gene have been shown to
cause this disorder. In contrast, the more common
syndrome, APS type II, typically manifesting in
adulthood, has polygenic inheritance. APS type
II is less well defined, but is strongly associated
with several specific HLA class II gene
polymorphisms .The chronic development of
organ-specific autoimmunity necessitates the
evaluation of patients with Evans’ syndrome over
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time. This suggests further that autoimmune
hemolytic anemia and idiopathic
thrombocytopenic purpura with Hashimoto’s
thyroiditis might share a common pathogenetic
pathway, the defect of which leads to Evans’
syndrome and should be classified as a new third
APS type.
In summary, we report a case of
Hashimoto’s thyroiditis complicated by Evans’
syndrome, and suggest that Evans’ syndrome
could be a high risk factor for autoimmune
thyroiditis. Patients with Evans’ syndrome should
be evaluated by thyroid function tests, including
those for thyroid auto-antibodies, to prevent the
development of overt hypo- or hyperthyroidism. .
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ECG Section
Diagnose the ECG Abnormalities
Dr. Ulhas M. Pandurangi MD, DM
The Previous issue (Volume 1, Issue 2, September-December 2009) quiz answer:
What is the complete diagnosis?
1. Hypertrophic Left Ventricular Cardiomyopathy
2. Hypertrophic Biventricular Cardiomyopathy
3. WPW Syndrome
4. Acute Coronary Syndrome
The correct answer is Hypertrophic Biventricular Cardiomyopathy
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Answer in the next issue.
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